Risk Assessment of Radiation Prevention and Treatment Drugs
10.3870/j.issn.1004-0781.2025.10.021
- VernacularTitle:辐射防治药物的风险评估
- Author:
Ran ZHANG
1
;
Chang LU
;
Huan LONG
;
Keer XUAN
;
Wanlong ZHANG
;
Yuxian ZHANG
;
Hongzhu LIU
;
Dong CHAI
;
Jian GONG
Author Information
1. 沈阳药科大学药物流行病与临床药物评价课题组,沈阳 110016
- Publication Type:Journal Article
- Keywords:
Radiation prevention and treatment drugs;
Anti-radiation;
Risk assessment;
Effectiveness;
Security
- From:
Herald of Medicine
2025;44(10):1648-1654
- CountryChina
- Language:Chinese
-
Abstract:
Radiation prevention and treatment drugs are a rapidly developing field.Radiation prevention and treatment drugs can be roughly divided into four categories:chemical synthetic drugs,biological products,natural plant extracts and traditional Chinese medicine compounds,which are widely used in medical,scientific research and other fields.This paper reviews the classification of radiation prevention and treatment drugs,which can be roughly divided into four categories:chemical synthetic drugs,biological products,natural plant extracts and traditional Chinese medicine compounds.At the same time,its mechanism of action and clinical application are elaborated in detail,and the risk assessment is carried out from the aspects of effectiveness,safety and drug interaction.Finally,the risk reduction strategies are summarized from the aspects of clinical medication specification and monitoring,continuous drug safety research,improvement of emergency reserve and support capacity and construction of full-cycle regulatory system,so as to provide reference for the rational application and further research of radiation prevention and treatment drugs.
